Search research articles
Contact Us
Filters
Showing results (71-80 of 111) with videos related to
Page
of 12
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
September 7, 2001
Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells
L S Metelitsa, O V Naidenko, A Kant, et al.
American Journal of Clinical Pathology
|
April 7, 2023
PROSER: A Web-Based Peripheral Blood Smear Interpretation Support Tool Utilizing Electronic Health Record Data
Mark S Iscoe, Andrew J Loza, Donald Turbiville, et al.
RMD Open
|
May 20, 2021
Guselkumab induces robust reduction in acute phase proteins and type 17 effector cytokines in active psoriatic arthritis: results from phase 3 trials
Kristen Sweet, Qingxuan Song, Matthew J Loza, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|
February 22, 2013
Nanotechnology in corneal neovascularization therapy--a review
Lilian Gonzalez, Raymond J Loza, Kyu-Yeon Han, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
August 14, 2018
A phase 2a study of toreforant, a histamine H<sub>4</sub> receptor antagonist, in eosinophilic asthma
Alexa P Kollmeier, Elliot S Barnathan, Christopher O'Brien, et al.
Annals of the American Thoracic Society
|
March 31, 2016
Longitudinally Stable, Clinically Defined Clusters of Patients with Asthma Independently Identified in the ADEPT and U-BIOPRED Asthma Studies
Matthew J Loza, Ian Adcock, Charles Auffray, et al.
Scientific Reports
|
October 3, 2024
Pharmacodynamic, prognostic, and predictive biomarkers in severe and critical COVID-19 patients treated with sirukumab
Kim Thys, Matthew J Loza, Linghua Lynn, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
April 24, 2018
Phase 2a, randomized, double-blind, placebo-controlled, multicentre, parallel-group study of an H<sub>4</sub> R-antagonist (JNJ-39758979) in adults with uncontrolled asthma
A P Kollmeier, A Greenspan, X L Xu, et al.
Therapeutic Advances in Musculoskeletal Disease
|
October 28, 2025
Safety, tolerability, and efficacy of the PD-1 agonist antibody JNJ-67484703 in adults with active rheumatoid arthritis: results of a multicenter, double-blind, placebo-controlled, randomized, multiple-dose phase Ib study
Irving T C Ling, Stanley J Marciniak, Stephen H Clarke, et al.
ERJ Open Research
|
December 28, 2023
Using an electronic diary and wristband accelerometer to detect exacerbations and activity levels in COPD: a feasibility study
Lydia J Finney, Stefan Avey, Dexter Wiseman, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 111) with videos related to
Sort By:
Page
of 12
Journal of Immunology (Baltimore, Md. : 1950)
|
September 7, 2001
Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells
L S Metelitsa, O V Naidenko, A Kant, et al.
American Journal of Clinical Pathology
|
April 7, 2023
PROSER: A Web-Based Peripheral Blood Smear Interpretation Support Tool Utilizing Electronic Health Record Data
Mark S Iscoe, Andrew J Loza, Donald Turbiville, et al.
RMD Open
|
May 20, 2021
Guselkumab induces robust reduction in acute phase proteins and type 17 effector cytokines in active psoriatic arthritis: results from phase 3 trials
Kristen Sweet, Qingxuan Song, Matthew J Loza, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|
February 22, 2013
Nanotechnology in corneal neovascularization therapy--a review
Lilian Gonzalez, Raymond J Loza, Kyu-Yeon Han, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
August 14, 2018
A phase 2a study of toreforant, a histamine H<sub>4</sub> receptor antagonist, in eosinophilic asthma
Alexa P Kollmeier, Elliot S Barnathan, Christopher O'Brien, et al.
Annals of the American Thoracic Society
|
March 31, 2016
Longitudinally Stable, Clinically Defined Clusters of Patients with Asthma Independently Identified in the ADEPT and U-BIOPRED Asthma Studies
Matthew J Loza, Ian Adcock, Charles Auffray, et al.
Scientific Reports
|
October 3, 2024
Pharmacodynamic, prognostic, and predictive biomarkers in severe and critical COVID-19 patients treated with sirukumab
Kim Thys, Matthew J Loza, Linghua Lynn, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
April 24, 2018
Phase 2a, randomized, double-blind, placebo-controlled, multicentre, parallel-group study of an H<sub>4</sub> R-antagonist (JNJ-39758979) in adults with uncontrolled asthma
A P Kollmeier, A Greenspan, X L Xu, et al.
Therapeutic Advances in Musculoskeletal Disease
|
October 28, 2025
Safety, tolerability, and efficacy of the PD-1 agonist antibody JNJ-67484703 in adults with active rheumatoid arthritis: results of a multicenter, double-blind, placebo-controlled, randomized, multiple-dose phase Ib study
Irving T C Ling, Stanley J Marciniak, Stephen H Clarke, et al.
ERJ Open Research
|
December 28, 2023
Using an electronic diary and wristband accelerometer to detect exacerbations and activity levels in COPD: a feasibility study
Lydia J Finney, Stefan Avey, Dexter Wiseman, et al.
Page
of 12